ASX Cannabis Stocks: Little Green Pharma Secures French Trial Tender for CBD50 - Kalkine Media

July 13, 2023 03:12 PM AEST | By Team Kalkine Media
Follow us on Google News:

Little Green Pharma, an Australian cannabis company listed on the Australian Securities Exchange (ASX), has recently secured a trial tender in France for its CBD50 product. This development highlights the progress and opportunities in the ASX cannabis stocks sector, particularly in the medicinal cannabis market.

Little Green Pharma's successful tender in France signifies its ability to expand its market reach and participate in international opportunities. The trial tender for CBD50, a cannabidiol (CBD) product, demonstrates the growing acceptance and recognition of the potential therapeutic benefits of cannabis-derived treatments.

This achievement can have significant implications for ASX LGP and the ASX cannabis stocks sector as a whole. It showcases the company's ability to navigate complex regulatory environments and establish partnerships on a global scale. Additionally, it highlights the increasing interest and demand for medical cannabis products in international markets.

Investors interested in ASX cannabis stocks should consider factors such as the company's product portfolio, regulatory environment, and market expansion strategies. It's important to conduct thorough research and analysis before making investment decisions, considering the unique risks and opportunities associated with the cannabis industry.


Little Green Pharma's successful tender in France for its CBD50 product underscores the growth potential and opportunities in the ASX cannabis stocks sector. This achievement demonstrates the company's ability to secure international partnerships and navigate regulatory landscapes. Investors interested in ASX cannabis stocks should carefully evaluate the company's fundamentals, market opportunities, and regulatory dynamics to make informed investment decisions in this evolving industry.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK